BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22666132)

  • 1. Immunocompetent mice model for dengue virus infection [corrected].
    Gonçalves D; de Queiroz Prado R; Almeida Xavier E; Cristina de Oliveira N; da Matta Guedes PM; da Silva JS; Moraes Figueiredo LT; Aquino VH
    ScientificWorldJournal; 2012; 2012():525947. PubMed ID: 22666132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing.
    Frias-Staheli N; Dorner M; Marukian S; Billerbeck E; Labitt RN; Rice CM; Ploss A
    J Virol; 2014 Feb; 88(4):2205-18. PubMed ID: 24335303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice.
    Costa VV; Fagundes CT; Valadão DF; Ávila TV; Cisalpino D; Rocha RF; Ribeiro LS; Ascenção FR; Kangussu LM; Celso MQ; Astigarraga RG; Gouveia FL; Silva TA; Bonaventura D; Sampaio Dde A; Leite AC; Teixeira MM; Souza DG
    Med Microbiol Immunol; 2014 Aug; 203(4):231-50. PubMed ID: 24723052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Heterotypic DENV-specific CD8
    Talarico LB; Batalle JP; Byrne AB; Brahamian JM; Ferretti A; García AG; Mauri A; Simonetto C; Hijano DR; Lawrence A; Acosta PL; Caballero MT; Paredes Rojas Y; Ibañez LI; Melendi GA; Rey FA; Damonte EB; Harris E; Polack FP
    EBioMedicine; 2017 Jun; 20():202-216. PubMed ID: 28483582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.
    Sarathy VV; White M; Li L; Gorder SR; Pyles RB; Campbell GA; Milligan GN; Bourne N; Barrett AD
    J Virol; 2015 Jan; 89(2):1254-66. PubMed ID: 25392217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Callithrix penicillata: a feasible experimental model for dengue virus infection.
    Ferreira MS; de Castro PH; Silva GA; Casseb SM; Dias Júnior AG; Rodrigues SG; Azevedo Rdo S; Costa e Silva MF; Zauli DA; Araújo MS; Béla SR; Teixeira-Carvalho A; Martins-Filho OA; Vasconcelos PF
    Immunol Lett; 2014; 158(1-2):126-33. PubMed ID: 24361035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.
    Pinto AK; Brien JD; Lam CY; Johnson S; Chiang C; Hiscott J; Sarathy VV; Barrett AD; Shresta S; Diamond MS
    mBio; 2015 Sep; 6(5):e01316-15. PubMed ID: 26374123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner.
    Fagundes CT; Costa VV; Cisalpino D; Amaral FA; Souza PR; Souza RS; Ryffel B; Vieira LQ; Silva TA; Atrasheuskaya A; Ignatyev G; Sousa LP; Souza DG; Teixeira MM
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1449. PubMed ID: 22206036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model.
    Sarathy VV; Infante E; Li L; Campbell GA; Wang T; Paessler S; Robert Beatty P; Harris E; Milligan GN; Bourne N; Barrett ADT
    J Gen Virol; 2015 Oct; 96(10):3035-3048. PubMed ID: 26296350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lethal model of disseminated dengue virus type 1 infection in AG129 mice.
    Milligan GN; Sarathy VV; White MM; Greenberg MB; Campbell GA; Pyles RB; Barrett ADT; Bourne N
    J Gen Virol; 2017 Oct; 98(10):2507-2519. PubMed ID: 28949904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide synthase expression correlates with death in an experimental mouse model of dengue with CNS involvement.
    de Souza KP; Silva EG; de Oliveira Rocha ES; Figueiredo LB; de Almeida-Leite CM; Arantes RM; de Assis Silva Gomes J; Ferreira GP; de Oliveira JG; Kroon EG; Campos MA
    Virol J; 2013 Aug; 10():267. PubMed ID: 23978258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of real time PCR for detection and quantitation of Dengue Viruses.
    Gurukumar KR; Priyadarshini D; Patil JA; Bhagat A; Singh A; Shah PS; Cecilia D
    Virol J; 2009 Jan; 6():10. PubMed ID: 19166574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models of dengue virus infection and disease.
    Yauch LE; Shresta S
    Antiviral Res; 2008 Nov; 80(2):87-93. PubMed ID: 18619493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity.
    Omatsu T; Moi ML; Hirayama T; Takasaki T; Nakamura S; Tajima S; Ito M; Yoshida T; Saito A; Katakai Y; Akari H; Kurane I
    J Gen Virol; 2011 Oct; 92(Pt 10):2272-2280. PubMed ID: 21697346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological and Pathological Landscape of Dengue Serotypes 1-4 Infections in Immune-Competent Mice.
    Rathore APS; Mantri CK; Tan MW; Shirazi R; Nishida A; Aman SAB; Morrison J; St John AL
    Front Immunol; 2021; 12():681950. PubMed ID: 34168651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional Profiling Confirms the Therapeutic Effects of Mast Cell Stabilization in a Dengue Disease Model.
    Morrison J; Rathore APS; Mantri CK; Aman SAB; Nishida A; St John AL
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28659489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First detection of dengue virus in the saliva of immunocompetent murine model.
    Rasinhas ADC; Silva MAND; Caldas GC; Jácome FC; Leonardo R; Santos FBD; Nunes PCG; Barth OM; Barreto-Vieira DF
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170208. PubMed ID: 29412340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain.
    Grifoni A; Angelo M; Sidney J; Paul S; Peters B; de Silva AD; Phillips E; Mallal S; Diehl SA; Botten J; Boyson J; Kirkpatrick BD; Whitehead SS; Durbin AP; Sette A; Weiskopf D
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques.
    Mladinich KM; Piaskowski SM; Rudersdorf R; Eernisse CM; Weisgrau KL; Martins MA; Furlott JR; Partidos CD; Brewoo JN; Osorio JE; Wilson NA; Rakasz EG; Watkins DI
    Immunogenetics; 2012 Feb; 64(2):111-21. PubMed ID: 21881953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.
    Amorim JH; Pereira Bizerra RS; dos Santos Alves RP; Sbrogio-Almeida ME; Levi JE; Capurro ML; de Souza Ferreira LC
    PLoS One; 2012; 7(9):e44984. PubMed ID: 23028722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.